Peer-reviewedCC BY-NC-NDTranslational cancer research
Lnc-TIM3 promotes acute lymphoblastic leukemia progression through miR-5094-mediated regulation of TIM3
- 1Department of Pediatrics , Jiangsu Taizhou People’s Hospital of Nanjing Medical University , Taizhou , ;
- 2Department of Hematology and Oncology , Children’s Hospital of Nanjing Medical University , Nanjing ,
Related
- Oncogenic CLDN1 promotes thyroid cancer progression through TAp63-mediated glycolytic switching
- JARID2 promotes prostate cancer progression associated with TET3-mediated activation of the FAK/PI3K/AKT signaling pathway
- KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma
- The Spliceosome Scaffold Component BCAS2 Promotes Pancreatic Cancer Progression through Weak 5 Splice Site Dependent Splicing Regulation
- SPP1-CD44-Mediated Crosstalk Between Endothelial and Macrophage Subpopulations Promotes Pancreatic Ductal Adenocarcinoma Progression Through S100A6 Upregulation
BibTeX
@article{sun2026lnctim3,
title = {{Lnc-TIM3 promotes acute lymphoblastic leukemia progression through miR-5094-mediated regulation of TIM3}},
author = {Jing Sun and Jiou Zhao and Wenfeng Fu and Huimin Li and Meiyun Kang and Yongjun Fang and Yaping Wang},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657841},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Lnc-TIM3 promotes acute lymphoblastic leukemia progression through miR-5094-mediated regulation of TIM3
AU - Jing Sun
AU - Jiou Zhao
AU - Wenfeng Fu
AU - Huimin Li
AU - Meiyun Kang
AU - Yongjun Fang
AU - Yaping Wang
PY - 2026
DA - 2026/08/28
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657841
SN - 2218-676X
ER -